Sundeep Santosh Salvi (Pune, India), Marjolein Brusse-Keizer (Enschede, Netherlands)
The frequency of COPD exacerbations is related to the comorbidity profile
Emin Hoxha Ekström (Gothenburg, Sweden), Emin Hoxha Ekström, Maria Andersson, Maria Gerhardsson de Verdier, Jan Hedner, Ann Ekberg Jansson, Max Petzold, Kjell Torén, Mikael Svensson
|  |
Relation of American Heart Association’s life’s simple 7 cardiovascular health factors with chronic obstructive pulmonary disease
Hwa Mu Lee (Anaheim, United States of America), Hwa Mu Lee, Angela Lee, Chi Kieu, Nathan Wong
|  |
Analysis of the frequency of COPD exacerbations in the ’real-life’ DACCORD study over a 2 year period
Heinrich Worth (Fürth, Germany), Heinrich Worth, Roland Buhl, Carl-Peter Criee, Peter Kardos, Claudia Mailänder, Nadine Lossi, Claus Vogelmeier
| |
Comorbidity in patients with IHD - the prevalence of COPD
Daria Didenko (Vinnitza, Ukraine), Daria Didenko, Lesya Rasputina, Yuriy Mostovoy, Nataliya Cherepii
| |
Risk of pneumonia in chronic obstructive pulmonary disease patients treated with inhaled corticosteroids. Results from the OUTPUL study
Nera Agabiti (Rome, Italy), Nera Agabiti, Silvia Cascini, Lisa Bauleo, Ursula Kirchmayer, Valeria Belleudi, Mirko Di Martino, Riccardo Pistelli, Giulio Formoso, Danilo Fusco, Marina Davoli
| |
Systematic analysis of self-reported comorbidities in the COSYCONET COPD cohort study by stepwise evaluation of medication
Rudolf A Jörres (Munich, Germany), Tanja Lucke, Ronald Herrera, Margarethe Wacker, Rolf Holle, Frank Biertz, Dennis Nowak, Rudolf Maria Huber, Sandra Söhler, Claus Vogelmeier, Joachim Ficker, Harald Mückter, Rudolf A. Jörres
| |
Prevalence of common diseases in COPD patients versus lung-healthy control subjects: Results from the German COSYCONET study
Stefan Karrasch (Neuherberg, Germany), Stefan Karrasch, Anne Obst, Sandra Söhler, Barbara Thorand, Cornelia Huth, Karl-Heinz Ladwig, Claudia Flexeder, Margarethe Wacker, Annette Peters, Joachim Heinrich, Ralf Ewert, Dennis Nowak, Rudolf A. Jörres, Claus Vogelmeier, Sven Gläser, Holger Schulz, COSYCONET Study Group
| |
One-year mortality in COPD patients after severe exacerbation
Evgeni Mekov (Sofia, Bulgaria), Evgeni Mekov, Yanina Slavova, Adelina Tsakova, Marianka Genova, Dimitar Kostadinov, Delcho Minchev, Dora Marinova, Mihail Boyanov
| |
2 years in the life of COPD patients: Evolution of GOLD 2011 classification in the ’real-life’ DACCORD study
Roland Buhl (Mainz, Germany), Roland Buhl, Carl-Peter Criée, Peter Kardos, Claus Vogelmeier, Claudia Mailänder, Nadine Lossi, Heinrich Worth
| |
Predictors of COPD in high risk individuals seen in primary care
Charlotte Suppli Ulrik (Virum, Denmark), Oliver Tupper, Peter Kjeldgaard, Anders Løkke, Charlotte Suppli Ulrik
| |
Global associations between air pollutants and chronic obstructive pulmonary disease (COPD) exacerbations: A systematic review
Elizabeth Moore (London, United Kingdom), Elizabeth Moore, Lia Chatzidiakou, Moyosore-Oluwa Kuku, Roderic Jones, Liam Smeeth, Sean Beevers, Frank Kelly, Benjamin Barratt, Jennifer Quint
| |
Validation of the COPD control concept: A UK pilot
Shawna Tan (Singapore, Singapore), Shawna Tan, Marc Miravitlles, Juan Jose Soler-Cataluna, Bernardino Alcazar, Anjan Nibber, Alison Chisholm, Joan B. Soriano, David Price
| |
Night-time symptoms and sleep disturbances in patients with COPD
Ulf Holmgren (Mölndal, Sweden), Ulf Holmgren, Mark Small, Gina Bergström, Bo Ding
| |
Comorbidities and COPD severity: The French Palomb cohort
Chantal Raherison-Semjen (Pessac, France), Chantal Raherison-Semjen, El-Hassane Ouaalaya, Laurent Falque, Alain Bernady, Jean-Michel Dupis, Marielle Sabatini, Laurent Nguyen, Annaig Ozier, Cecilia Nocent-Eijnaini, Frederic Le Guillou, Christophe Roy, Elodie Blanchard, Helene Jungmann, Julien Casteigt, Emilie Berteaud, Francois Pellet
| |
Prevalence of comorbidities in patients with chronic obstructive pulmonary disease in presence of heart failure
Dulce Gonzalez (Ciudad de Mexico, Mexico), Rafael Hernández-Zenteno, Brenda Santellano-Juárez, Arturo Orea-Tejeda, Dulce Gonzalez, Juan Pineda-Juárez, Rocío Sánchez-Santillán, Viridiana Peláez-Hernández, Alejandra Velázquez-Montero, Carlos Cíntora-Martínez, Raúl Herrera-Saucedo, Elisa Pérez-Cabañas, Edna Contreras-Ramírez, Raúl Sansores-Martínez
| |
Co-morbidities and pulmonary arterial hypertension (PAH) in COPD patients
Velin Stratev (Varna, Bulgaria), Velin Stratev, Tanya Dobreva, Valentina Dimitrova, Diana Petkova
| |
Prolonged length of hospital stay associated with the type of heart failure in patients with chronic obstructive pulmonary disease
José Ernesto Juárez León (Mexico City, Mexico), Ernesto Juárez-León, Brenda Santellano-Juárez, Arturo Orea-Tejeda, Dulce Gonzalez, Rocío Sánchez-Santillán, Juan Pineda-Juárez, Viridiana Peláez-Hernández, Carlos Cíntora-Martínez, Raúl Herrera-Saucedo, Elisa Pérez-Cabañas, Edna Contreras-Ramírez, Gerardo Leija-Alba, Raúl Sansores-Martínez, Alejandra Velázquez-Montero
| |
COPD exacerbations and predictors in a general population
Marta Erdal (Bergen, Norway), Marta Erdal, Ane Johannessen, Tomas Eagan, Per Bakke, Amund Gulsvik, Rune Grønseth
| |
Cardiovascular risk assessment in COPD patients with severe exacerbation
Evgeni Mekov (Sofia, Bulgaria), Evgeni Mekov, Yanina Slavova, Adelina Tsakova, Marianka Genova, Dimitar Kostadinov, Delcho Minchev, Dora Marinova, Mihail Boyanov
| |
Psychiatric co-morbidity in patients admitted with acute exacerbation of chronic pulmonary disease and its relationship with symptom severity
Claire Blackmore (Kettering, United Kingdom), Claire Blackmore, S.F. Hussain, N.J. Greening, J.E. Williams, T.C. Harvey-Dunstan, E.J. Chaplin, R. Chimera, M.D. Morgan, S.J. Singh, M.C. Steiner
| |